Squamous Cell Carcinoma Antigen, Serum
Use
The Squamous Cell Carcinoma Antigen test is useful for aiding in the evaluation and monitoring of squamous cell carcinoma of the head and neck, lung, and cervix. It should not be used for screening for carcinoma or other disorders, as its utility is limited to certain types of squamous cell carcinomas. Squamous cell carcinoma (SCC) of the skin is the second most common form of skin cancer and squamous cell carcinoma antigen represents a subfraction of tumor-associated antigens used as a serum tumor marker.
Special Instructions
Not provided.
Limitations
Elevated concentrations of squamous cell carcinoma antigen may also occur in non-cancerous conditions such as kidney insufficiency, psoriasis, and asthma. There is a potential for a 'hook effect' causing falsely low concentrations in cases of extremely elevated antigen levels. Human anti-mouse antibodies (HAMA) may interfere with the test, which is method dependent, and results obtained with different assays should not be used interchangeably.
New York Approved
Methodology
Immunoassay (Immunofluorescent Assay)
Biomarkers
Squamous Cell Carcinoma Antigen (SCCA)
Protein
LOINC Codes
- 9679-2
- 9679-2
Result Turnaround Time
1-7 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
0.5 mL
Minimum Volume
0.2 mL
Container
Plastic vial
Collection Instructions
Centrifuge and aliquot serum into a plastic vial. Do not submit in original tube.
Causes for Rejection
Gross hemolysis, Gross icterus
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 7 days |
| Refrigerated | 7 days |
| Frozen | 90 days |